Suppr超能文献

透析服务的提供以及卫生经济学对腹膜透析利用的影响:马来西亚视角的综述

Dialysis Provision and Implications of Health Economics on Peritoneal Dialysis Utilization: A Review from a Malaysian Perspective.

作者信息

Abdul Manaf Mohd Rizal, Surendra Naren Kumar, Abdul Gafor Abdul Halim, Seong Hooi Lai, Bavanandan Sunita

机构信息

Department of Community Health, Faculty of Medicine, Pusat Perubatan Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia.

Nephrology Unit, Faculty of Medicine, Pusat Perubatan Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia.

出版信息

Int J Nephrol. 2017;2017:5819629. doi: 10.1155/2017/5819629. Epub 2017 Oct 31.

Abstract

End-stage renal disease (ESRD) is managed by either lifesaving hemodialysis (HD) and peritoneal dialysis (PD) or a kidney transplant. In Malaysia, the prevalence of dialysis-treated ESRD patients has shown an exponential growth from 504 per million population (pmp) in 2005 to 1155 pmp in 2014. There were 1046 pmp patients on HD and 109 pmp patients on PD in 2014. Kidney transplants are limited due to lack of donors. Malaysia adopts public-private financing model for dialysis. Majority of HD patients were treated in the private sector but almost all PD patients were treated in government facilities. Inequality in access to dialysis is visible within geographical regions where majority of HD centres are scattered around developed areas. The expenditure on dialysis has been escalating in recent years but economic evaluations of dialysis modalities are scarce. Evidence shows that health policies and reimbursement strategies influence dialysis provision. Increased uptake of PD can produce significant economic benefits and improve patients' access to dialysis. As a result, some countries implemented a PD-First or Favored Policy to expand PD use. Thus, a current comparative costs analysis of dialysis is strongly recommended to assist decision-makers to establish a more equitable and economically sustainable dialysis provision in the future.

摘要

终末期肾病(ESRD)通过挽救生命的血液透析(HD)、腹膜透析(PD)或肾移植进行治疗。在马来西亚,接受透析治疗的ESRD患者患病率呈指数增长,从2005年的每百万人口504例增长至2014年的每百万人口1155例。2014年,有1046例每百万人口的患者接受血液透析,109例每百万人口的患者接受腹膜透析。由于缺乏捐赠者,肾移植受限。马来西亚采用公私合营的透析融资模式。大多数血液透析患者在私立部门接受治疗,但几乎所有腹膜透析患者都在政府机构接受治疗。在地理区域内,透析服务的可及性存在不平等,大多数血液透析中心分布在发达地区。近年来,透析费用不断攀升,但对透析方式的经济评估却很少。有证据表明,卫生政策和报销策略会影响透析服务的提供。增加腹膜透析的使用可以产生显著的经济效益,并改善患者获得透析的机会。因此,一些国家实施了优先使用腹膜透析或支持腹膜透析的政策,以扩大腹膜透析的使用。因此,强烈建议进行当前透析的比较成本分析,以协助决策者在未来建立更公平、经济上可持续的透析服务。

相似文献

2
Dialysis provision in Malaysia.
Med J Malaysia. 2000 Jun;55(2):188-95.
6
Peritoneal dialysis in Asia.亚洲的腹膜透析
Perit Dial Int. 1996;16 Suppl 1:S381-5.
7
[REIN Report 2011--summary].[2011年肾脏疾病改善全球结果(KDIGO)报告——摘要]
Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1.
10
Peritoneal Dialysis in Asia.亚洲的腹膜透析。
Kidney Dis (Basel). 2015 Dec;1(3):147-56. doi: 10.1159/000439193. Epub 2015 Sep 11.

引用本文的文献

5
Peritoneal dialysis: Status report in South and South East Asia.腹膜透析:南亚和东南亚的现状报告。
Nephrology (Carlton). 2021 Nov;26(11):898-906. doi: 10.1111/nep.13949. Epub 2021 Aug 6.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验